PT Millennium Pharmacon International Tbk (SDPC.JK)
IDR 132.0
(0.76%)
IDR 132.0
(0.76%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 273.37 Billion IDR | 1.39% |
| 2022 | 269.63 Billion IDR | 11.53% |
| 2021 | 241.75 Billion IDR | 9.05% |
| 2020 | 221.69 Billion IDR | -3.09% |
| 2019 | 228.75 Billion IDR | 8.85% |
| 2018 | 210.15 Billion IDR | 17.01% |
| 2017 | 179.59 Billion IDR | 6.12% |
| 2016 | 169.24 Billion IDR | 7.59% |
| 2015 | 157.3 Billion IDR | 19.59% |
| 2014 | 131.53 Billion IDR | 9.19% |
| 2013 | 120.46 Billion IDR | 15.32% |
| 2012 | 104.45 Billion IDR | 19.77% |
| 2011 | 87.21 Billion IDR | 8.71% |
| 2010 | 80.23 Billion IDR | -14.99% |
| 2009 | 94.38 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 79.23 Billion IDR | 0.14% |
| 2024 Q2 | 79.12 Billion IDR | -3.78% |
| 2024 Q1 | 82.22 Billion IDR | 15.09% |
| 2023 Q1 | 69.46 Billion IDR | 3.13% |
| 2023 FY | 273.37 Billion IDR | 1.39% |
| 2023 Q4 | 71.44 Billion IDR | -3.72% |
| 2023 Q3 | 74.2 Billion IDR | 2.77% |
| 2023 Q2 | 72.2 Billion IDR | 3.95% |
| 2022 Q3 | 70.8 Billion IDR | 13.81% |
| 2022 Q4 | 67.35 Billion IDR | -4.88% |
| 2022 Q1 | 69.25 Billion IDR | 19.06% |
| 2022 FY | 269.63 Billion IDR | 11.53% |
| 2022 Q2 | 62.21 Billion IDR | -10.17% |
| 2021 Q2 | 60.73 Billion IDR | 9.92% |
| 2021 FY | 241.75 Billion IDR | 9.05% |
| 2021 Q4 | 58.17 Billion IDR | -13.94% |
| 2021 Q3 | 67.59 Billion IDR | 11.3% |
| 2021 Q1 | 55.25 Billion IDR | 6.64% |
| 2020 FY | 221.69 Billion IDR | -3.09% |
| 2020 Q4 | 51.81 Billion IDR | 0.52% |
| 2020 Q1 | 68.01 Billion IDR | 24.55% |
| 2020 Q2 | 50.31 Billion IDR | -26.03% |
| 2020 Q3 | 51.54 Billion IDR | 2.45% |
| 2019 Q2 | 60.02 Billion IDR | 4.75% |
| 2019 FY | 228.75 Billion IDR | 8.85% |
| 2019 Q1 | 57.3 Billion IDR | 6.59% |
| 2019 Q4 | 54.6 Billion IDR | -3.89% |
| 2019 Q3 | 56.81 Billion IDR | -5.35% |
| 2018 Q3 | 56.25 Billion IDR | 5.2% |
| 2018 FY | 210.15 Billion IDR | 17.01% |
| 2018 Q1 | 46.66 Billion IDR | 6.68% |
| 2018 Q2 | 53.47 Billion IDR | 14.59% |
| 2018 Q4 | 53.76 Billion IDR | -4.43% |
| 2017 FY | 179.59 Billion IDR | 6.12% |
| 2017 Q1 | 44.08 Billion IDR | 3.6% |
| 2017 Q2 | 44.27 Billion IDR | 0.42% |
| 2017 Q3 | 47.49 Billion IDR | 7.28% |
| 2017 Q4 | 43.74 Billion IDR | -7.9% |
| 2016 Q1 | 43.55 Billion IDR | -2.75% |
| 2016 FY | 169.24 Billion IDR | 7.59% |
| 2016 Q4 | 42.55 Billion IDR | 12.88% |
| 2016 Q3 | 37.7 Billion IDR | -17.01% |
| 2016 Q2 | 45.42 Billion IDR | 4.29% |
| 2015 Q2 | 38.87 Billion IDR | 6.28% |
| 2015 Q1 | 36.57 Billion IDR | -2.29% |
| 2015 FY | 157.3 Billion IDR | 19.59% |
| 2015 Q4 | 44.78 Billion IDR | 20.84% |
| 2015 Q3 | 37.06 Billion IDR | -4.65% |
| 2014 Q1 | 31.45 Billion IDR | -8.71% |
| 2014 FY | 131.53 Billion IDR | 9.19% |
| 2014 Q3 | 31.35 Billion IDR | 0.19% |
| 2014 Q2 | 31.29 Billion IDR | -0.5% |
| 2014 Q4 | 37.43 Billion IDR | 19.4% |
| 2013 Q3 | 29.76 Billion IDR | 6.58% |
| 2013 Q2 | 27.92 Billion IDR | -1.35% |
| 2013 Q4 | 34.45 Billion IDR | 15.75% |
| 2013 FY | 120.46 Billion IDR | 15.32% |
| 2013 Q1 | 28.31 Billion IDR | 4.69% |
| 2012 FY | 104.45 Billion IDR | 19.77% |
| 2012 Q3 | 25.44 Billion IDR | 0.0% |
| 2012 Q4 | 27.04 Billion IDR | 6.28% |
| 2011 FY | 87.21 Billion IDR | 8.71% |
| 2010 FY | 80.23 Billion IDR | -14.99% |
| 2009 FY | 94.38 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 2913.35 Billion IDR | 90.616% |
| PT Itama Ranoraya Tbk | 127.06 Billion IDR | -115.153% |
| PT Kimia Farma (Persero) Tbk | 2780.27 Billion IDR | 90.167% |
| PT Soho Global Health Tbk | 1257.75 Billion IDR | 78.265% |